Encompass Health raises 2026 outlook as Q3 demand and margins strengthen

Transcript intelligence

What changed

Compared with the prior quarter, management continued its confident, expansion-oriented stance but emphasized stronger Q3 results, four hospital openings, a larger 15-hospital pipeline, broader Medicare Advantage admit-and-appeal expansion, and new one-off and regulatory risks.

Guidance delta

Management raised 2026 revenue and earnings guidance after Q3 performance exceeded expectations.

Key takeaways

• Stroke and VA volumes remained important growth drivers, while higher acuity supported pricing.
• Capacity expansion accelerated, with four new hospitals opened in Q3 and a 15-hospital, 654-bed pipeline beyond 2026.
• Labor cost controls continued, but management expects diminishing returns from further premium-labor reductions.

Management priorities

• Expand inpatient rehabilitation capacity through new hospitals and bed additions.
• Scale the Medicare Advantage admit-and-appeal strategy to more diagnoses and hospitals.
• Continue capital allocation toward repurchases, modest dividend increases, and growth capex.